ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,340.30
-0.40%
S&P ASX All Technology
3,885.50
-0.28%
Brent Oil
73.045
-0.05%
US Dollar vs AUD
1.52952
0.02%
Bitcoin
91,967.25
-0.40%
Pepperstone
Advertisement
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Korro Bio Inc (KRRO) Share Price

Korro Bio Inc

Korro Bio Inc (KRRO)

NASDAQ
46.37
-0.26
(-0.56%)
Closed 20 November 8:00AM
Delayed by 15 minutes
46.63
0.26
(0.56%)
After Hours: 9:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
46.37
Bid
43.00
Offer
51.45
Volume
94,263
44.65 Day's Range 48.1899
30.005 52 Week Range 98.00
Market Cap
431.186M
Previous Close
46.63
Open
45.75
Last Trade
1
@
46.63
Last Trade Time
Financial Volume
US$ 4,372,499
VWAP
46.3862
Average Volume (3m)
120,498
Shares Outstanding
9,298,815
Dividend Yield
-
PE Ratio
-5.31
Earnings Per Share (EPS)
-8.73
Revenue
-
Net Profit
-81.17M

About Korro Bio Inc

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to cre... Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.korrobio.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Korro Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KRRO. The last closing price for Korro Bio was US$46.63. Over the last year, Korro Bio shares have traded in a share price range of US$ 30.005 to US$ 98.00.

Korro Bio currently has 9,298,815 shares in issue. The market capitalisation of Korro Bio is US$433.60 million. Korro Bio has a price to earnings ratio (PE ratio) of -5.31.

Ask ADVFN Intelligence (AI)

KRRO Latest News

More News

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

15 November 2024
Edgar (US Regulatory)

Korro to Present at the Jefferies London Healthcare Conference

CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA...

15 November 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

13 November 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

13 November 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

13 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

13 November 2024
Edgar (US Regulatory)

Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates

- Submitted regulatory filing for first-in-human clinical study of KRRO-110 in patients with alpha-1 antitrypsin deficiency (AATD) - Formed Clinical Advisory Board (CAB) of leading lung and liver...

13 November 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

13 November 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

04 November 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-25.44-35.426820777171.8172.5146.191816278754.25755869CS
4-29.63-38.98684210537677.1346.191813273462.51682761CS
12-1.83-3.7966804979348.29830.7412049860.05335014CS
26-9.62-17.181639578555.999830.0059930951.37589779CS
5210.127.846705266136.279830.0056786253.11841305CS
15633.37256.6923076921398137054552.10510752CS
26033.37256.6923076921398137054552.10510752CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRFXPainReform Ltd
US$ 1.35
(152.34%)
195.81M
NCNCnoco noco Inc
US$ 0.1652
(70.31%)
767.43M
NXTTNext Technology Holding Inc
US$ 2.7699
(62.94%)
3.73M
SMCXDefiance Daily Target 2X Long SMCI ETF
US$ 41.475
(62.52%)
4.18M
TRNRInteractive Strength Inc
US$ 3.93
(55.34%)
25.79M
SLNSilence Therapeutics PLC
US$ 6.99
(-36.57%)
4.53M
AKTXAkari Therapeutics PLC
US$ 1.57
(-31.44%)
316.64k
QMMMQMMM Holdings Limited
US$ 1.25
(-27.75%)
4.54M
DMNDamon Inc
US$ 1.75
(-27.39%)
992.36k
GDHGGolden Heaven Group Holdings Ltd
US$ 1.50
(-26.47%)
316.77k
NCNCnoco noco Inc
US$ 0.1652
(70.31%)
760.1M
SYRSSyros Pharmaceuticals Inc
US$ 0.2718
(36.72%)
365.6M
WBUYWeBuy Global Ltd
US$ 0.1931
(21.37%)
251.48M
SMCISuper Micro Computer Inc
US$ 28.30
(31.38%)
229.27M
NVDANVIDIA Corporation
US$ 147.01
(4.89%)
225.53M

Discussion

View Full Feed
dmiller dmiller 1 minute ago
Many co's announce a buyback but never purchase a single share. I believe this co will just add to that list. Maybe Denner thinks the stock is overvalued lol.
AMRN
dinogreeves dinogreeves 1 minute ago
Bad yes, but definitely not bad enough. Bought at 0.0029, 4.3 million shares, sold the most at 0.0026 and the rest at 0.0024. See not too bad. Hicks loves you so much.
AFFU
New money98 New money98 2 minutes ago
Like the R-2 exhibits?
The Night Stalker The Night Stalker 2 minutes ago
can run
VHAI
Wingsjr Wingsjr 2 minutes ago
Keefe who? If they wanted to dilute or wipe out the shareholders, they would’ve done it along time ago, they can’t do it and they know if they try to take any more of our wealth that there will be a huge class action lawsuit that will end their plans of releasing Fannie and Freddie until all legal a
FNMA
Doc logic Doc logic 2 minutes ago
JerryCampbell,

No I don’t “know this” because as flipper44 and dstock pointed out the statistics point to DCVax-L improvement in outcomes based on no single factor including percent of resection although that was the one of 2 factors closest to actually favoring patient outcomes even
NWBO
delerious1 delerious1 3 minutes ago
there has never been anything like it.... it’s wonderful, it’s a beautiful thing.....like nobody has seen before......
NBRI
bar1080 bar1080 3 minutes ago
Jeesh, I almost lost track of my decades-long Cintas holding. It just keeps rising and rising. Other than the split, it's a pretty quiet money maker.
CTAS
Tesla Trillionaire Tesla Trillionaire 3 minutes ago
$400 by EOY and 2025 brings new all time highs. 2026-2029 bring record market caps never reached by a single company. 
TSLA
pinkslipjunkie pinkslipjunkie 4 minutes ago
Mod squad alert...LOL
AFFU
Zorch305 Zorch305 4 minutes ago
Well I'm down about $40 on it overall but I was buying at .01 before reverse split at one point I picked up very little so no big deal if this shits the bed I highly doubt it will
RDAR
The Night Stalker The Night Stalker 4 minutes ago
need ss update
SINC
GrandAdmiralThrawn GrandAdmiralThrawn 4 minutes ago
Yeah, if you want to bring people here to talk about any stock, go ahead. Like I said, this board has no focus, people can talk about whatever they want
mascale mascale 4 minutes ago
So Anyone continues: "Tiny bubbles (tiny bubbles), Make me warm all over: With a feeling that I'm gonna Love you till the end of time"
HIRU
dmiller dmiller 5 minutes ago
You think strangers can hurt my feelings? You really have no clue about me but by all means, continue to amuse me :)
AMRN
CanItBThisEZ2Make CanItBThisEZ2Make 5 minutes ago
$MAXN
Buy: 511,249
Neutral: 161,459
Sell: 653,503
Volume: 1,326,211
MAXN
RobotDroid RobotDroid 6 minutes ago
Nobody with sense wants to deal with a mute inept non pr'ing LP.
NWBO
RickNagra RickNagra 6 minutes ago
$4 by Friday.
FNMA
The Night Stalker The Night Stalker 6 minutes ago
nice
SYRS
igotthemojo igotthemojo 7 minutes ago
this is a supplement to an original filing that came out in June...and im pretty sure most of this filing was copied and pasted from earlier filings...

so that statement was accurate, but is old...is it still valid?...thats up to you...

kim does tend to just leave the f
KBLB
GolfnutBoston GolfnutBoston 7 minutes ago
Get lost, you made a bad trade. Deal with it. Be a man 
AFFU
Orange Cassidy Orange Cassidy 8 minutes ago
Lets see the rally cry for sticking together as a group CHECK the call for share price at multipennys CHECK The im not selling claim CHECK only thing that is missing is "i know what I own" claim. This is the usual scheme you see all too many times on this website.
NBRI
1vman 1vman 8 minutes ago
*****🚽HIRU🚽 15 Million - XPERT Sells !!! PEE YEW !!! Stinky OTC pinky her

https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades

ENOUGH SAID HUZZAH🤪 !!!
HIRU
RobotDroid RobotDroid 8 minutes ago
Year, 123 million new shares in a year is business as usual. The stupidity here is astounding.
NWBO
HoldEm777 HoldEm777 8 minutes ago
That’s refreshing. Thank you.

Your Recent History

NASDAQ
KRRO
Korro Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved